| MPI RESEARCH ACQUIRES
FAST SYSTEMS, INC. |
MPI Research is pleased to announce the
acquisition of FAST Systems, Inc., an immunotoxicology
provider. FAST Systems, now a Division of
MPI Research, is located in Gaithersburg,
Maryland.
With the addition of FAST Systems, MPI Research
now offers a wide range of immunotoxicology
capabilities and customized assays using
flow cytometry, which includes immunophenotyping,
NK cell cytotoxicity assay, macrophage and
neutrophil phagocytosis assays, mitogen-
and drug-induced lymphocyte proliferation,
and detection of intracellular cytokines
(Th1 and Th2 pathways). These assays are
consistent with the recent FDA Guidelines
entitled, “Immunotoxicology Evaluation
of Investigational New Drugs,” and
are an integral part of the new general toxicity
testing requirements. Assays can be conducted
in mice, rats, nonhuman primates, dogs,
and pigs and conducted in compliance with
Good Laboratory Practices.
MPI Research now has the capability to develop
new immunotoxicology assays to fit any research
program. Combining the elements of immunotoxicology
into its current toxicology services and
capabilities, demonstrates MPI Research’s
ongoing desire to develop new technologies
to meet the ever expanding needs of our customers.
Dr. Marlon C. Rebelatto, Director of Immunotoxicology,
commented, “This acquisition provides
an ideal combination of experiences for immunotoxicity
testing. Together, we will provide reliable
and customized studies to fulfill our sponsors’ needs
in immunotoxicology.”
Dr. M. J. Waxdal, Division President, commented, ”We
are very excited about joining MPI Research.
This association expands our offering of
state of the art science to our clients.”
MPI Research has the vision to become the
best, full service non-clinical contract
research organization in the industry.
MPI Research exists to provide comprehensive
non-clinical research that meets the requirements
of pharmaceutical, animal health and chemical
companies as well as governmental agencies
as we partner together to bring safer, healthier
products to the world. MPI employees specialize
in a wide variety of scientific disciplines
including toxicology, pharmacology, metabolism,
pathology, clinical pathology, reproductive
and developmental biology, veterinary science,
neuroscience, analytical chemistry, immunotoxicology,
computer science, regulatory science, and
statistics.
Home | News
|